Penetrium Bioscience Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 5,850.00
+750.00 (14.71%)
At close: Sep 4, 2026
Penetrium Bioscience Market Cap
Penetrium Bioscience has a market cap or net worth of 320.37 billion as of September 4, 2026. Its market cap has increased by 138.44% in one year.
Market Cap
320.37B
Enterprise Value
323.62B
Revenue
9.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,850.00
ChartMarket Cap Chart
Since June 3, 2021, Penetrium Bioscience's market cap has increased from 215.74B to 320.37B, an increase of 48.49%. That is a compound annual growth rate of 7.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 320.37B | 145.80% |
| Dec 30, 2025 | 130.34B | 86.73% |
| Dec 30, 2024 | 69.80B | 57.99% |
| Dec 28, 2023 | 44.18B | 1.39% |
| Dec 29, 2022 | 43.58B | -66.41% |
| Dec 30, 2021 | 129.71B | -39.88% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ingenia Therapeutics | 782.21B |
| DreamCIS | 81.18B |
| P&K Skin Research Center | 52.91B |
| HLB bioStep | 41.66B |
| Kolmar BioTech | 35.34B |
| SLS BIO | 26.89B |
| C&R Research | 22.74B |
| DT&CRO CO. | 19.66B |